Senate kills proposed OTC energy regulation

The US Senate has blocked a measure to re-regulate the trading of over-the-counter (OTC) energy derivatives. Dianne Feinstein, a Democratic Senator from California, had proposed a bill amendment that would permit the Commodity Futures Trading Commission to regulate OTC trading in energy and metals derivatives, in the wake of Enron’s collapse.

The measure was defeated on a routine procedural vote that required 60 affirmative votes for the amendment to advance. Feinstein’s proposals received 48 votes, forcing her to withdraw her amendment, admitting it lacked sufficient support "at this time".

Texan Republican Senator Phil Gramm led the opposition to the proposals, with support from Alan Greenspan, chairman of the Federal Reserve, and Paul O'Neill, the US Treasury secretary.

The International Swaps and Derivatives Association, and other trade associations, also urged the Senate to vote against the proposals, noting that Feinstein’s amendments unfairly applied to OTC metals derivatives, which have no connection to either the Enron collapse or the Californian energy crisis.

Feinstein had previously rejected a request from Gramm, the top-ranking Republican on the Senate Banking Committee, to exempt metals derivatives and to drop price-transparency requirements from her proposed reforms.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Stemming the tide of rising FX settlement risk

As the trading of emerging markets currencies gathers pace and broader uncertainty sweeps across financial markets, CLS is exploring alternative services designed to mitigate settlement risk for the FX market

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here